NDAINTRAVENOUSPOWDER
Approved
Jan 2023
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC 99M MERTIATIDE KIT (technetium tc 99m mertiatide) by Jubilant Therapeutics is imaging, technetium tc 99m mertiatide is rapidly cleared from the blood. First approved in 2023.
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Technetium Tc 99m Mertiatide is a diagnostic imaging agent administered intravenously as a reconstituted powder kit. It is rapidly cleared from blood and excreted by the kidneys, enabling renal and urinary tract imaging. This radiopharmaceutical is used for functional assessment of the renal system.
Peak
Product is at peak commercial maturity with moderate competitive pressure (30/100), indicating stable revenue but limited growth runway for commercial expansion.
Mechanism of Action
imaging, Technetium Tc 99m Mertiatide is rapidly cleared from the blood. It is cleared by the kidneys and excreted in the urine.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Technetium Tc 99m Mertiatide positions you in the niche but stable diagnostic imaging market with a mature product at peak commercialization. Career growth is more likely through deepening expertise in nuclear medicine and hospital channel relationships than through blockbuster-scale expansion opportunities.
Diagnostic Imaging SpecialistMedical Affairs Manager
Worked on TECHNETIUM TC 99M MERTIATIDE KIT at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.